Ocular Melanoma - 43 Studies Found

Not yet recruiting : Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal Melanoma
: Uveal Melanoma
: 2017-02-14
:
  • Biological: IMCgp100 IMCgp100

Active, not recruiting : Trial of Nivolumab in Combination With Ipilimumab in Subjects With Previously Untreated Metastatic Uveal Melanoma
: Uveal Melanoma
: 2015-12-01
:
  • Drug: ipilimumab Ipilimumab ev
Recruiting : A Study of the Intra-Patient Escalation Dosing Regimen With IMCgp100 in Patients With Advanced Uveal Melanoma
: Uveal Melanoma
: 2015-10-06
: Drug: IMCgp100 Bispecific soluble HLA-A2 restricted gp100-specific TCR fused to anti-CD3
Completed : Evaluation Interest of the Circulating Tumor DNA Dosage in Patient With Hepatic Metastatic Uveal Melanoma Candidate to Complete Resection (ct DNA R0)
: Uveal Melanoma
: 2016-07-13
: Biological: Blood sampling 7,5 ml of patient peripherical blood will be collected at each blood sample.
Completed : Study of Metastatic Ocular Melanoma
: Ocular Melanoma
: 2005-09-09
:
  • Drug: Gemcitabine
  • Drug: Treosulfan
Active, not recruiting : STA-9090(Ganetespib) in Metastatic Ocular Melanoma
: Ocular Melanoma
: 2010-09-10
: Drug: STA-9090 Given intravenously once week or twice a week for three weeks of a four week cycle
Completed : Sorafenib and Radioembolization With Sir-Spheres® for the Treatment of Metastatic Ocular Melanoma
: Ocular Melanoma
: 2013-07-02
:
  • Drug: Sorafenib Sorafenib will
Active, not recruiting : Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Ocular Melanoma
:
  • Metastatic Ocular Melanoma
  • Metastatic Uveal Melanoma

: 2013-03-15
:
  • Drug: Aldesleukin Aldeskeukin

Completed : THE IPI - Trial in Advanced Melanoma: Melanoma Patients With Advanced Disease
: Ocular Melanoma
: 2010-12-29
: Drug: Ipilimumab Ipilimumab monotherapy 3mg/kg by four infusion every 3 weeks
Not yet recruiting : Definity for Ultrasound of Intraocular Tumors
: Ocular Melanoma
: 2013-02-28
<<< Previous | Next >>>